TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Feb 01, 2021 14:00 JST
Source:
Takex Co., Ltd.
Lasting Antiviral Effect against Covid-19 virus (SARS-CoV-2) by TAKEX CLEAN EXTRA
An ethanol sanitizer with Bamboo extract
Verifies 99.99% of virus inactivation even after 15 days
Osaka, Japan, Feb 01, 2021 - (JCN Newswire) - Takex Co., Ltd. (Headquarters: Suita City, Osaka Prefecture / President and CEO: Kumi Okada), the company engaged in the research and development of bamboo for about 34 years since the development of a sanitizer by using bamboo extract in 1987, announces that it has conducted a verification test of TAKEX CLEAN EXTRA (bamboo extract-containing ethanol sanitizer) against Covid-19 virus (SARS-CoV-2) and confirmed 99.99% of the virus inactivation even after 15 days.
TAKEX CLEAN EXTRA used for this test is a food grade ethanol sanitizer containing Bamboo extract, extracted from bamboo skin. It also provides assurance for the users as TAKEX CLEAN EXTRA is Halal certified by JAKIM, Malaysia government certification body which is highly recognized in other countries as well. TAKEX CLEAN EXTRA is manufactured in Kuala Lumpur, Malaysia and now on sale in Malaysia, Singapore, Indonesia (Product name is MAZTEX CLEAN EXTRA) and Thailand (Product name is TAKETSUYU).
Takex will continue to create products which contribute to the health and safety of people through the research and development of bamboo.
Summary and result of the evaluation test
[Covid-19 virus strain used for the test]
SARS-CoV-2 JPN/TY/WK-521 (Provided by National Institute of Infectious Diseases)
[Summary of test]
- Test center: Japan Textile Products Quality and Technology Center
- Test sample: TAKEX CLEAN EXTRA (Bamboo extract-containing ethanol preparation)
- Operative temperature: 25 degrees C
- Measurement of infectivity titer: Plaque assay
- Date of preparation of test specimen: December 3, 2020
- Date of testing: December 18, 2020
[Test method]
1. Apply the test sample on 50mm x 50mm plates and dry them. Store the plates for 15 days to use as test specimens.
2. Inoculate 0.40ml of the test virus inoculum onto the 15 days-old test specimens.
3. After covering with a PE film (40mm x 40mm) and contacting at 25 degrees C and a relative humidity of not less than 90% for 24 hours, add 10ml of wash-out solution onto each specimen.
4. Rub the surface of each specimen and film to wash out the virus.
5. Determine the virus infectivity titer by plaque assay.
[Test result]
It is confirmed that 99.99% of the virus became inactive after 15 days of TAKEX CLEAN EXTRA application.
[Test standard]
ISO21702
What is Bamboo extract
Bamboo extract is obtained from the crushed sheath of the stem of a gramineous Moso bamboo grown in Japan using special extraction method. It is approved as a food additive in Japan under Ministry of Health, Labor and Welfare, which confirm the safety of itself.
Takex confirmed in a research with Osaka Prefecture University that Bamboo extract was effective to inactivate feline calicivirus, an alternative virus of norovirus which is one of the agents of food poisoning. Also, in another research with Tottori University, it confirmed that the extract was effective to inactivate a bird flu virus (H5N3).
About Takex Co., Ltd.
https://takex-co.com/en/
Takex has been developing, manufacturing and selling hygiene products and shelf-life improvement agents that contain active ingredients extracted from bamboo since it developed a sanitizer using Bamboo extract in 1987. Targeting not only the Japanese market but also overseas and Halal markets, Takex is offering antibacterial and sanitizing agents, freshness-keeping agents, food additives, and others which obtain halal certification by JAKIM, Malaysia in the halal market.
Takexco Malaysia Sdn. Bhd. is a subsidiary company of Takex Co., Ltd. in Malaysia, which was established in September 2017. For the Covid-19 virus test and products detailed information, please refer attached reference document.
[Distributor in Indonesia]
PT Mazta Farma;
https://www.maztafarma.com
Address: Green Sedayu Biz Park DM 16 No.36, Jl. Daan Mogot KM.18, Kalideres, Jakarta Barat - DKI Jakarta
Contact Phone Number: +6221-22527412
Email address:
marketing@maztafarma.co.id
&
maztexcleanextra@gmail.com
Official SNS: IG: @maztexofficial, FB: Maztex Indonesia
Media contact
Takex PR office (within Kyodo PR)
E-mail:
takex-pr@kyodo-pr.co.jp
Source: Takex Co., Ltd.
Sectors: Daily News, Healthcare & Pharm, Local Biz
Copyright ©2026 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Press Release
Marketing Authorization Application for In-house Developed Insomnia Drug Lemborexant Accepted for Evaluation by European Medicines Agency (EMA)
Jul 18, 2026 00:24 JST
Hitachi and NVIDIA collaborate to advance HMAX and enable end-to-end autonomous operations through the integrated control of physical AI
Jul 17, 2026 23:35 JST
Toyota's First "BE creation" Spin-Off Begins Operations in Japan
Jul 17, 2026 23:00 JST
MHI Advances AI Infrastructure Commercialization with U.S. Deployment of 10MW-Class Chiller and MCP Development
Jul 17, 2026 22:47 JST
Noetra Launches Full-Scale R&D for Japan-Developed Multimodal Foundation Model
Jul 17, 2026 22:16 JST
Mitsubishi Motors Launches the Xforce HEV in Indonesia
Jul 17, 2026 21:47 JST
Fujitsu to explore physical AI development and implementation across industries with FANUC, Yaskawa Electric, and Kawasaki Heavy Industries integrating NVIDIA technology
Jul 17, 2026 21:05 JST
JCB Celebrates 30 Years of Trust, Honoring 70 Years of Japan-Philippines Friendship
Jul 17, 2026 10:00 JST
TANAKA Commences Operation of "TANAKA H2 Nexus", One of Japan's Largest 500 kW Pure Hydrogen Fuel Cell Power Generation Facilities
Jul 16, 2026 22:00 JST
LEQEMBI(R) Real-World LEADER Study Presented at AAIC(R) 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
Jul 16, 2026 00:18 JST
FDA Approves LEQEMBI IQLIK(R) (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
Jul 15, 2026 23:51 JST
Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's Association International Conference(R) (AAIC(R)) 2026
Jul 15, 2026 23:21 JST
NEC develops world's first proprietary-AI technology to rapidly generate highly detailed 3D models solely from general-purpose camera footage while automatically removing unnecessary subjects
Jul 15, 2026 22:53 JST
Hitachi Rail achieves EcoVadis platinum medal, ranking among the top 1% of companies worldwide for sustainability performance
Jul 15, 2026 22:35 JST
Anime Tokyo Station Reaches 300,000 Visitors!
Jul 15, 2026 11:00 JST
Fujitsu launches AI-driven modernization service to accelerate legacy system transformation
Jul 14, 2026 19:12 JST
Anime Tokyo Station: TV Anime "BLEACH: THE BLOOD WARFARE - The Calamity" Special Exhibition
Jul 14, 2026 11:00 JST
JCB Signs Memorandum of Understanding with Circle to Explore Collaboration Utilizing Stablecoins
Jul 14, 2026 10:00 JST
Mitsubishi Power Receives Contract to Supply Boilers for Fuel Conversion Work at Existing Thermal Power Plants in Saudi Arabia
Jul 14, 2026 00:58 JST
Fujitsu developed an AI Agent to collaborate with store managers for AEON Food Style's strategic store operations
Jul 14, 2026 00:38 JST
More Latest Release >>